rinri-therapeutics2024-07-02T10:24:09+00:00Rinri Therapeutics latest article has been published by Otology and Neurotology.Press Release July 02, 2024
rinri-therapeutics2024-04-29T06:48:21+00:00Rinri Therapeutics Announces New Chair as It Approaches First Clinical TrialPress Release April 29th, 2024
rinri-therapeutics2024-03-05T10:01:16+00:00World’s first self-monitored cochlear implant trial opens the door to future hearing loss therapiesPress Release December 13th, 2022
rinri-therapeutics2024-03-05T12:52:54+00:00International research coalition verifies safe surgical access to the central core of the human cochlea for the very first timePress Release November 9th, 2022
rinri-therapeutics2024-03-05T12:53:31+00:00Rinri Therapeutics accelerates first regenerative cell therapy for hearing loss towards clinic with key senior hires and award of Innovation PassportPress Releases May 3rd, 2022
rinri-therapeutics2024-03-05T12:54:15+00:00Rinri Therapeutics Raises £10 million from Existing Investors and UK Future Fund to Advance its Novel Stem Cell Therapy to Restore Hearing LossPress Release April 20th, 2021
rinri-therapeutics2024-03-05T12:54:37+00:00Ground-breaking study to measure hearing healthPress Release January 11th, 2021
rinri-therapeutics2024-03-05T12:55:01+00:00Rinri Therapeutics secures £1.4 million seed funding to advance its novel regenerative cell therapy to treat sensorineural hearing lossPress Release May 20th, 2019